125 related articles for article (PubMed ID: 8500500)
1. Optimal variants of treatment of stage I endometrial carcinoma and its choice.
Charkviani TL
Eur J Gynaecol Oncol; 1993; 14(2):154-9. PubMed ID: 8500500
[TBL] [Abstract][Full Text] [Related]
2. [Combined treatment and prognostic factors for stage III and IV endometrial carcinoma].
Ren YL; Wang HY; Shi DR; Yang WT; Sun Z; Chen Y
Zhonghua Fu Chan Ke Za Zhi; 2008 Jul; 43(7):523-7. PubMed ID: 19080517
[TBL] [Abstract][Full Text] [Related]
3. Favourable influence of adjuvant hormone therapy by oxyprogesterone caproate (OPC) and by its combination with tamoxifen on 5-year survival rate of surgical and combined treatment of primary endometrial carcinoma patients.
Vishnevsky AS; Bokhman YaV ; Loutfi G
Eur J Gynaecol Oncol; 1993; 14(2):150-3. PubMed ID: 8500499
[TBL] [Abstract][Full Text] [Related]
4. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma.
Hiura M; Nogawa T; Matsumoto T; Yokoyama T; Shiroyama Y; Wroblewski J
Int J Gynecol Cancer; 2010 Aug; 20(6):1000-5. PubMed ID: 20683408
[TBL] [Abstract][Full Text] [Related]
5. The diagnosis and treatment of endometrial cancer: progress and controversies.
Denschlag D; Ulrich U; Emons G
Dtsch Arztebl Int; 2010 Aug; 108(34-35):571-7. PubMed ID: 21904591
[TBL] [Abstract][Full Text] [Related]
6. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant progestagen therapy improves survival in patients with endometrial cancer after hysterectomy. Results of one-institutional prospective clinical trial.
Urbański K; Karolewski K; Kojs Z; Klimek M; Dyba T
Eur J Gynaecol Oncol; 1993; 14 Suppl():98-104. PubMed ID: 8200383
[TBL] [Abstract][Full Text] [Related]
8. [Therapeutic modalities of endometrial carcinoma in stage I and II].
Sun J; Sheng X; Chou Z
Zhonghua Fu Chan Ke Za Zhi; 1997 Oct; 32(10):601-4. PubMed ID: 9642376
[TBL] [Abstract][Full Text] [Related]
9. Morphological aspects of the hormone-induced pathomorphosis of endometrial carcinoma.
Chepick OF
Eur J Gynaecol Oncol; 1993; 14(2):144-9. PubMed ID: 8500498
[TBL] [Abstract][Full Text] [Related]
10. The significance of the amount of myometrial invasion in patients with Stage IB endometrial carcinoma.
Alektiar KM; McKee A; Lin O; Venkatraman E; Zelefsky MJ; Mychalczak BR; McKee B; Hoskins WJ; Barakat RR
Cancer; 2002 Jul; 95(2):316-21. PubMed ID: 12124832
[TBL] [Abstract][Full Text] [Related]
11. Significant pelvic recurrence in high-risk pathologic stage I--IV endometrial carcinoma patients after adjuvant chemotherapy alone: implications for adjuvant radiation therapy.
Mundt AJ; McBride R; Rotmensch J; Waggoner SE; Yamada SD; Connell PP
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1145-53. PubMed ID: 11483323
[TBL] [Abstract][Full Text] [Related]
12. Influence of body mass index on clinicopathologic features, surgical morbidity and outcome in patients with endometrial cancer.
Akbayır O; Corbacıoglu Esmer A; Numanoglu C; Cılesız Goksedef BP; Akca A; Bakır LV; Kuru O
Arch Gynecol Obstet; 2012 Nov; 286(5):1269-76. PubMed ID: 22729137
[TBL] [Abstract][Full Text] [Related]
13. Endometrial cancer in premenopausal women 45 years and younger.
Gitsch G; Hanzal E; Jensen D; Hacker NF
Obstet Gynecol; 1995 Apr; 85(4):504-8. PubMed ID: 7898824
[TBL] [Abstract][Full Text] [Related]
14. Excellent long-term survival and absence of vaginal recurrences in 332 patients with low-risk stage I endometrial adenocarcinoma treated with hysterectomy and vaginal brachytherapy without formal staging lymph node sampling: report of a prospective trial.
Eltabbakh GH; Piver MS; Hempling RE; Shin KH
Int J Radiat Oncol Biol Phys; 1997 May; 38(2):373-80. PubMed ID: 9226326
[TBL] [Abstract][Full Text] [Related]
15. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma.
Creutzberg CL; van Putten WL; Koper PC; Lybeert ML; Jobsen JJ; Wárlám-Rodenhuis CC; De Winter KA; Lutgens LC; van den Bergh AC; van de Steen-Banasik E; Beerman H; van Lent M
Lancet; 2000 Apr; 355(9213):1404-11. PubMed ID: 10791524
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant hormone therapy of primary endometrial carcinoma with oxyprogesterone caproate.
Bokhman JV; Chepick OF; Volkova AT; Vishnevsky AS
Gynecol Oncol; 1981 Jun; 11(3):371-8. PubMed ID: 6788657
[No Abstract] [Full Text] [Related]
17. [The surgical and radiotherapy treatment of endometrial adenocarcinoma. A retrospective analysis of 128 patients].
Sacco M; Rotta P; Rampino M
Radiol Med; 1991 Nov; 82(5):658-63. PubMed ID: 1780466
[TBL] [Abstract][Full Text] [Related]
18. Postoperative external beam radiation therapy and concurrent cisplatin followed by carboplatin/paclitaxel for stage III (FIGO 2009) endometrial cancer.
Milgrom SA; Kollmeier MA; Abu-Rustum NR; Tew WP; Sonoda Y; Barakat RR; Alektiar KM
Gynecol Oncol; 2013 Sep; 130(3):436-40. PubMed ID: 23800696
[TBL] [Abstract][Full Text] [Related]
19. The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer.
Alvarez Secord A; Havrilesky LJ; Bae-Jump V; Chin J; Calingaert B; Bland A; Rutledge TL; Berchuck A; Clarke-Pearson DL; Gehrig PA
Gynecol Oncol; 2007 Nov; 107(2):285-91. PubMed ID: 17688923
[TBL] [Abstract][Full Text] [Related]
20. Surgery and postoperative radiation therapy in FIGO Stage IIIC endometrial carcinoma.
Mundt AJ; Murphy KT; Rotmensch J; Waggoner SE; Yamada SD; Connell PP
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1154-60. PubMed ID: 11483324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]